专利检索 ap:("XIN CHEN" OR "PENG CHENG" OR "L. EDWARD CLEMENS" OR "JEFFREY D. JOHNSON" OR "JINGYUAN MA" OR "ALISON MURPHY" OR "IMAD NASHASHIBI" OR "CHRISTOPER J. RABBAT" OR "JIANGAO SONG" OR "MARIA E. WILSON" OR "YAN ZHU" OR "ZUCHUN ZHAO") AND inv:"CHRISTOPER J. RABBAT" 第 1 页

1.

发明申请
HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS 有权

公开(公告)号：US20100130511A1

公开(公告)日：2010-05-27

申请号：US12619577

申请日：2009-11-16

申请人： XIN CHEN , PENG CHENG , L. EDWARD CLEMENS , JEFFREY D. JOHNSON , JINGYUAN MA , ALISON MURPHY , IMAD NASHASHIBI , CHRISTOPER J. RABBAT , JIANGAO SONG , MARIA E. WILSON , YAN ZHU , ZUCHUN ZHAO

发明人： XIN CHEN , PENG CHENG , L. EDWARD CLEMENS , JEFFREY D. JOHNSON , JINGYUAN MA , ALISON MURPHY , IMAD NASHASHIBI , CHRISTOPER J. RABBAT , JIANGAO SONG , MARIA E. WILSON , YAN ZHU , ZUCHUN ZHAO

IPC分类号： A61K31/506 , A61P3/10

CPC分类号： A61K31/506 , A61K31/454 , C07D277/42 , C07D401/04 , C07D401/14 , C07D413/04 , C07D413/14 , C07D417/04 , C07D417/14

摘要： Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active.